Retatrutide's Potential to Overcome GLP-1 Weight-Loss Challenges | Retatrutide News

Retatrutide, a new GLP-1 agonist by Eli Lilly, may address weight-loss plateaus seen with current therapies. The article explores its potential impact o...
Weight Loss · October 20, 2026